InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by STAAB THOMAS R II, Chief Financial Officer. Insider active across 2 companies, notably Tenax Therapeutics, INC.. Cumulatively, 4 reports have been published. The latest transaction was filed on 11 May 2026 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations4 total
010,000 shares0
Common Stock
SEC:0001193125-26-221926·
010,000 shares0
Common Stock
SEC:0001193125-26-221926:0·
015,000 shares0
Common Stock
SEC:0000899243-22-001924·
015,000 shares0
Common Stock
SEC:0000899243-22-001924:0·
4 of 4 declarations
About STAAB THOMAS R II
Thomas R. Staab II is the Chief Financial Officer at Tenax Therapeutics, Inc. and LENSAR, Inc. He oversees the financial and strategic operations of both companies. His role is crucial in ensuring their financial health and supporting their growth in the market.
